Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) — The “Prefilled Syringes – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Prefilled Syringes was estimated at US$7.5 Billion in 2023 and is projected to reach US$13.3 Billion by 2030, growing at a CAGR of 8.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers and forecasts.
How Are Technological Advancements Enhancing Prefilled Syringes?
Technological advancements have significantly improved the design, functionality, and safety of prefilled syringes. Innovations in materials science have led to the development of advanced polymers and glass alternatives that enhance the durability and break resistance of syringes, reducing the risk of breakage and ensuring the integrity of the medication. Advances in manufacturing processes have improved the precision and consistency of syringe filling, ensuring accurate dosing and reducing variability between batches. The integration of safety features, such as needle guards and auto-disable mechanisms, has enhanced the safety of prefilled syringes, reducing the risk of needle stick injuries and preventing reuse.
Additionally, the development of dual-chamber prefilled syringes has enabled the delivery of lyophilized drugs that require reconstitution at the point of use, expanding the range of medications that can be delivered via prefilled syringes. These technological improvements have expanded the applications and benefits of prefilled syringes, making them a more versatile and reliable option for drug delivery.
What Are the Key Applications and Benefits of Prefilled Syringes?
Prefilled syringes are used in a wide range of medical applications, offering numerous benefits that enhance drug administration and patient care. In vaccine administration, prefilled syringes ensure accurate dosing and reduce the risk of contamination, making them ideal for large-scale immunization programs. In chronic disease management, prefilled syringes are used to deliver medications such as insulin, anticoagulants, and biologics, where precise dosing and ease of use are critical for patient adherence and outcomes. In emergency medicine, prefilled syringes provide a rapid and reliable means of delivering life-saving medications, such as epinephrine for anaphylaxis, where time is of the essence.
The primary benefits of prefilled syringes include improved safety, enhanced convenience, accurate dosing, and reduced waste, making them a preferred choice for both healthcare providers and patients. By simplifying the administration process and ensuring consistent dosing, prefilled syringes contribute to better patient care and outcomes across various therapeutic areas.
What Factors Are Driving the Growth in the Prefilled Syringes Market?
The growth in the prefilled syringes market is driven by several factors. The increasing demand for biologics and vaccines, which require precise and sterile delivery methods, is a significant driver, boosting the adoption of prefilled syringes in clinical settings. Technological advancements that enhance the safety, functionality, and compatibility of prefilled syringes with a wide range of medications are also propelling market growth. The rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, which require regular injections, is further boosting the demand for prefilled syringes.
Additionally, the growing preference for self-administration of medications, driven by the expansion of home healthcare, is contributing to the increased adoption of user-friendly prefilled syringes. The emphasis on reducing healthcare-associated infections (HAIs) and improving patient safety is further supporting the market growth. These factors, coupled with the continuous innovation in syringe design and materials, are driving the sustained growth of the prefilled syringes market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Conventional Prefilled Syringes segment, which is expected to reach US$8.8 Billion by 2030 with a CAGR of a 9%. The Safety Prefilled Syringes segment is also set to grow at 7.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, which was estimated at $2 Billion in 2023, and China, forecasted to grow at an impressive 11.6% CAGR to reach $3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Key Questions Answered:
- How is the Global Prefilled Syringes Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 179 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $7.5 Billion |
| Forecasted Market Value (USD) by 2030 | $13.3 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- World Market Trajectories
- Prefilled Syringes – Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
FOCUS ON SELECT PLAYERS
- Baxter International, Inc.
- Becton, Dickinson and Company
- Gerresheimer AG
- Medtronic PLC
- SCHOTT AG
- Stevanato Group Company
- Terumo Corporation
- Unilife Corporation
- Vetter Pharma International
- West Pharmaceutical Services
MARKET TRENDS & DRIVERS
- Rising Prevalence of Chronic Diseases Drives Demand for Prefilled Syringes
- Technological Advancements in Syringe Design and Materials Propel Market Growth
- Increasing Adoption of Self-administration of Medications Expands Addressable Market Opportunity
- Focus on Reducing Medication Errors Strengthens Business Case for Prefilled Syringes
- Growing Popularity of Biologics and Biosimilars Throws the Spotlight on Prefilled Syringes
- Government Initiatives to Improve Vaccination Rates Accelerate Market Demand
- Rising Geriatric Population Enhances Market Prospects
- Increasing Focus on Patient Safety and Compliance Drives Market Dynamics
- Expansion of Home Healthcare Services Boosts Market Adoption
- Growing Investments in Manufacturing and R&D Generates Innovation
- Focus on Minimizing Contamination Risk Sustains Market Growth
- Adoption of Smart Syringes with Safety Features Enhances Market Opportunities
- Rising Demand for Point-of-care Administration Expands Market Reach
For more information about this report visit https://www.researchandmarkets.com/r/4igj6f
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Prefilled Syringes Market
